THE RISK OF PEPTIC ULCER BLEEDING IS HIGHEST IN H. PYLORI POSITIVE PATIENTS ON COMBINED ANTIPLATELET THERAPY

(1) Dept. of Gastroenterology, Hepatology and Infectious Diseases,OTTO-VON-GUERICKE UNIVERSITY,Magdeburg,Germany

(2) Institute for Biometrics and Medical Informatics,OTTO-VON-GUERICKE UNIVERSITY,Magdeburg,Germany



This item was part of UEG Week 2015

This item can be cited as: United European Gastroenterology Journal; 2015: 2 (Supplement 1)